Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
November 19, 2016
Gene expression profiling of breast cancer in Lebanese women
Joelle Makoukji, Nadine J Makhoul, Maya Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Patient-Derived Three-Dimensional Lung Tumor Models to Evaluate Response to Immunotherapy
Kayla F Goliwas, Kenneth P Hough, Sruti Sivan, et al.
NPJ Precision Oncology
|
March 1, 2026
A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors
Gerald Falchook, Camila Braganca Xavier, David Van Veenhuyzen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2017
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis
Arafat Tfayli, Hind Rafei, Alain Mina, et al.
NPJ Precision Oncology
|
June 16, 2026
Patient-derived three-dimensional lung tumor models to evaluate response to therapy
Kayla F Goliwas, Aakash Desai, Kenneth P Hough, et al.
JCO Precision Oncology
|
June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
Gordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
JCO Precision Oncology
|
October 16, 2025
Olaparib in Patients With Solid Tumors With <i>BRCA1/2</i> Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Michael Rothe, Pam K Mangat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
November 19, 2016
Gene expression profiling of breast cancer in Lebanese women
Joelle Makoukji, Nadine J Makhoul, Maya Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Patient-Derived Three-Dimensional Lung Tumor Models to Evaluate Response to Immunotherapy
Kayla F Goliwas, Kenneth P Hough, Sruti Sivan, et al.
NPJ Precision Oncology
|
March 1, 2026
A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors
Gerald Falchook, Camila Braganca Xavier, David Van Veenhuyzen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2017
Prevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective Analysis
Arafat Tfayli, Hind Rafei, Alain Mina, et al.
NPJ Precision Oncology
|
June 16, 2026
Patient-derived three-dimensional lung tumor models to evaluate response to therapy
Kayla F Goliwas, Aakash Desai, Kenneth P Hough, et al.
JCO Precision Oncology
|
June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
Gordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
JCO Precision Oncology
|
October 16, 2025
Olaparib in Patients With Solid Tumors With <i>BRCA1/2</i> Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Tareq Al Baghdadi, Michael Rothe, Pam K Mangat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Page
of 3